Details of the Phase II trial24 Apr 2020 21:29
ww.clinicaltrialsregister.eu/ctr-search/trial/2020-001023-14/GB
Probably some of you already seen this, but I just came across it. The above link has very detailed description of the SNG001 Phase II trial, here are a few points :
Title of the trial : A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients with COVID-19
D.3.1 Product name : Interferon beta-1a (IFN-ß1a)
D.3.2 Product code : SNG001
E.1.1 Medical condition(s) being investigated : COVID-19
E.2.1 Main objective of the trial : To assess whether SNG001 is well tolerated, and can prevent or accelerate recovery of lower respiratory tract illness in patients with SARS-CoV-2 infection.
F.1.2 Adults (18-64 years): Yes
F.1.2.1 Number of subjects for this age range: 100
F.1.3 Elderly (>=65 years): Yes
F.1.3.1 Number of subjects for this age range: 300